Launching a new product is a high-stakes endeavor. IPM leads cross-functional commercialization projects for pharma and medical device companies, minimizing time to market and maximizing patient outcomes.
When bringing new drugs, medical devices, or other treatments to market, timing is critical. Complex new product types and accelerated product pipelines provide rich opportunities to benefit patients. However, complexity and speed have also made the process more challenging. Few companies have the expertise needed to deal with these new realities while leading cross-functional teams to launch and manage products. With IPM you access both life science market knowledge and best-in-class program and project management skills to guide commercialization. IPM can lead your team through product launch, marketing and advertising, preparing sales reps, working with payer requirements, and ongoing customer support.
The stakes in the commercialization of drug and medtech products are higher than ever. The reimbursement landscape is evolving and a launch needs to succeed quickly.
To ensure success, IPM applies proven methods for managing cross-functional teams and delivering products to market quickly. Our commercialization experts will:
Our approach to commercialization ensures you get the most value out of your products, from product launch to retirement.
IPM will lead commercialization workshops to create a schedule and comprehensive launch plan based on industry best practices and your unique needs. From start to finish in the commercialization process, IPM ensures effective collaboration with marketing and sales, medical affairs, market access, manufacturing and supply chain, vendor relations, and other key functions.
It takes best-in-class project management skills to break down silos and lead cross-functional teams to a launch success. A commercial launch plan from IPM addresses governance, risk management, and communication management to ensure seamless execution and a timely launch. When strategic alliances or co-developed products are involved, IPM provides additional stakeholder management to keep everyone informed and aligned.
Product extensions may include new indications, delivery methods, technology, or packaging. Rebate programs can reduce access barriers. Sunsetting products enables patients to transition to improved therapies. From post-launch analysis to end-of-life retirement, IPM can lead your lifecycle management projects to ensure patients have ongoing access to critical treatments.
With more than 60 launch readiness and post launch commercialization projects under our belt, IPM has the experience needed to get new therapies and medical devices to market faster. We’ve planned, managed, and supported the commercialization and lifecycle strategies for a wide variety of products ranging from orphan drugs to mass market therapies, as well as branded and generic/biosimilar products and combination therapies. We’ve helped clients navigate the complexities of an evolving reimbursement landscape.
Whether you are part of a single-product company or a large global organization, IPM has the expertise, resources, and skills to deliver commercialization success.